Analytical Essay Bipolar Disorder
Anylytical essay on SCHIZOPHRENIA
Contents Page
Abstract 2 Introduction 3
Impact on Family 4
Medication Adherence/ Non Adherence 6
Prevention through Risk Identification 7
Conclusion 10
References 11
Abstract
Schizophrenia is a psychotic mental disorder that is defined by Alanen "as a serious mental illness that usually becomes manifest in adolescence or early adulthood" (Alanen, 1997). Spearing furthers this definition to note that schizophrenia is a socially, financially and emotionally crippling disorder for not only the patient, but also the family unit (Spearing 2002). McGorry notes that in 2002 the economic cost of schizophrenia for Australia alone was $85 billion (McGorry, 2003). This cost can only be expected to grow, as in 2001, 17,731 patients were hospitalized nation wide for schizophrenic related problems, an increase in hospitalizations when compared with numbers from 2000 (AIHW Hospital Morbidity Database 2001-2002, 2004).
In Westernized countries such as Australia and North America, a period of approximately twelve months lapses between the manifestation of early symptoms of schizophrenia and the first course of treatment (Martinex and Garcia, 2002). Martinex and Garcia 's research further indicates that such a lengthy time lapses is often detrimental to a patient 's long term health and well being. Martinex and Garcia conclude that if the first psychosis is not treated immediately then relapse is far more likely and frequent (Martinex and Garcia, 2002). Much of the information
Contents Page
Abstract 2 Introduction 3
Impact on Family 4
Medication Adherence/ Non Adherence 6
Prevention through Risk Identification 7
Conclusion 10
References 11
Abstract
Schizophrenia is a psychotic mental disorder that is defined by Alanen "as a serious mental illness that usually becomes manifest in adolescence or early adulthood" (Alanen, 1997). Spearing furthers this definition to note that schizophrenia is a socially, financially and emotionally crippling disorder for not only the patient, but also the family unit (Spearing 2002). McGorry notes that in 2002 the economic cost of schizophrenia for Australia alone was $85 billion (McGorry, 2003). This cost can only be expected to grow, as in 2001, 17,731 patients were hospitalized nation wide for schizophrenic related problems, an increase in hospitalizations when compared with numbers from 2000 (AIHW Hospital Morbidity Database 2001-2002, 2004).
In Westernized countries such as Australia and North America, a period of approximately twelve months lapses between the manifestation of early symptoms of schizophrenia and the first course of treatment (Martinex and Garcia, 2002). Martinex and Garcia 's research further indicates that such a lengthy time lapses is often detrimental to a patient 's long term health and well being. Martinex and Garcia conclude that if the first psychosis is not treated immediately then relapse is far more likely and frequent (Martinex and Garcia, 2002). Much of the information
References: Allanen,O.,(1997).Schizophrenia: It 's origins and need adapted treatment. Barlow, D. H., & Durand, V. M. (1999). Abnormal psychology: an integrative approach (2nd Ed.). Pacific Grove: Brooks/Cole Pub. Co. Brady N, M. G. (2004). Living with schizophrenia: a family perspective. Online J Issues Nurse., 29, (1):7 Champion, L, Hoffman, J. (2004). Review of mental health emergency services in Western Australia. Retrieved 4 October, 2005, from http://www.carerswa.asn.au/uploadedfiles/MH%20Review.pdf Keltner,N Martinex, J. A. M., & Garcia, J. F. G. (2002). Family intervention program in schizophrenia: two year follow-up of the Andalusia study. Psychology in Spain, 6(1), 56-60. McGorry,P. Kathryn Elkins, Martin Lambert, Tim Lambert. (2003). Summary Australian New Zealand Clinical Practice Guideline for the Treatment of Schizophrenia. Australasian Psychiatry, 11(2), 136-147. Spearing,M.K.(2002) Overview of Schizophrenia: National Institute of mental health. Yung, A. R., Phillips, L.J., Yuen, H. P., & McGorry, P. D. (2004). Risk Factors for pychosis in ultra high risk group: pychopathy and clinical features. Schizophrenia Research, 67(2-3), 131-142.